Spezielle Aspekte der Analgosedierung bei Patienten mit kardiogenem Schock

详细信息    查看全文

• 作者：Dr. H. Lemm ; M. Janusch ; M. Buerke
• 关键词：Myokardinfarkt ; Sedierung ; Analgesie ; Pharmakotherapie ; Beatmung ; Myocardial infarction ; Conscious sedation ; Analgesia ; Pharmacotherapy ; Ventilation
• 刊名：Medizinische Klinik
• 出版年：2016
• 出版时间：February 2016
• 年：2016
• 卷：111
• 期：1
• 页码：22-28
• 全文大小：507 KB
• 参考文献：1.Bernhard M, Bein B, Böttiger BW, Bohn A, Fischer M, Gräsner JT, Hinkelbein J, Kill C, Lott C, Popp E, Roessler M, Schaumberg A, Wenzel V, Hossfeld B (2015) Handlungsempfehlung zur prähospitalen Notfallnarkose beim Erwachsenen: Arbeitsgruppe „Prähospitale Notfallnarkose“ des Wissenschaftlichen Arbeitskreises Notfallmedizin der Deutschen Gesellschaft für Anästhesiologie und Intensivmedizin. Notfall Rettungsmedizin 18:395–412. doi:10.1007/s10049-015-0041-9CrossRef
  2.Bignami E, Biondi-Zoccai G, Landoni G, Fochi O, Testa V, Sheiban I, Giunta F, Zangrillo A (2009) Volatile anesthetics reduce mortality in cardiac surgery. J Cardiothorac Vasc Anesth 23:594–599. doi:10.1053/j.jvca.2009.01.022CrossRef PubMed
  3.Brusco L (2002) Choice of sedation for critically Ill patients A Rational. Adv Stud Med 2:343–349
  4.Culp KE, Augoustides JG, Ochroch AE, Milas BL (2004) Clinical management of cardiogenic shock associated with prolonged propofol infusion. Anesth Analg 99:221–226. doi:10.1213/01.ANE.0000117285.12600.C1CrossRef PubMed
  5.Deng J, Lei C, Chen Y, Fang Z, Yang Q, Zhang H, Cai M, Shi L, Dong H, Xiong L (2014) Neuroprotective gases – Fantasy or reality for clinical use? Prog Neurobiol 115:210–245. doi:10.1016/j.pneurobio.2014.01.001CrossRef PubMed
  6.Elliott P, O’Hare R, Bill KM, Phillips AS, Gibson FM, Mirakhur RK (2000) Severe cardiovascular depression with remifentanil. Anesth Analg 91:58–61. doi:10.1213/00000539-200007000-00011PubMed
  7.Ely EW, Truman B, Shintani A, Thomason JWW, Wheeler AP, Gordon S, Francis J, Speroff T, Gautam S, Margolin R, Sessler CN, Dittus RS, Bernard GR (2003) Monitoring sedation status over time in ICU patients: reliability and validity of the Richmond Agitation-Sedation Scale (RASS). JAMA 289:2983–2991. doi:10.1001/jama.289.22.2983CrossRef PubMed
  8.Ethuin F, Boudaoud S, Leblanc I, Troje C, Marie O, Levron J-C, Le Moing J-P, Assoune P, Eurin B, Jacob L (2003) Pharmacokinetics of long-term sufentanil infusion for sedation in ICU patients. Intensive Care Med 29:1916–1920. doi:10.1007/s00134-003-1920-yCrossRef PubMed
  9.Fleisher LA, Fleischmann KE, Auerbach AD, Barnason SA, Beckman JA, Bozkurt B, Davila-Roman VG, Gerhard-Herman MD, Holly TA, Kane GC, Marine JE, Nelson MT, Spencer CC, Thompson A, Ting HH, Uretsky BF, Wijeysundera DN (2014) 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: executive summary a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 130:2215–2245. doi:10.1161/CIR.0000000000000105CrossRef PubMed
  10.Kugler J, Schwab RS (1981) Elektroenzephalographie in Klinik und Praxis: eine Einführung, 3. überarb. und erw. Aufl. Thieme, Stuttgart
  11.Landoni G, Biondi-Zoccai GGL, Zangrillo A, Bignami E, D’Avolio S, Marchetti C, Calabrò MG, Fochi O, Guarracino F, Tritapepe L, De Hert S, Torri G (2007) Desflurane and sevoflurane in cardiac surgery: a meta-analysis of randomized clinical trials. J Cardiothorac Vasc Anesth 21:502–511. doi:10.1053/j.jvca.2007.02.013CrossRef PubMed
  12.Landoni G, Augoustides JG, Guarracino F, Santini F, Ponschab M, Pasero D, Rodseth RN, Biondi-Zoccai G, Silvay G, Salvi L, Camporesi E, Comis M, Conte M, Bevilacqua S, Cabrini L, Cariello C, Caramelli F, De Santis V, Del Sarto P, Dini D, Forti A, Galdieri N, Giordano G, Gottin L, Greco M, Maglioni E, Mantovani L, Manzato A, Meli M, Paternoster G, Pittarello D, Rana KN, Ruggeri L, Salandin V, Sangalli F, Zambon M, Zucchetti M, Bignami E, Alfieri O, Zangrillo A (2011) Mortality reduction in cardiac anesthesia and intensive care: results of the first International Consensus Conference. Acta Anaesthesiol Scand 55:259–266. doi:10.1111/j.1399–6576.2010.02381.xCrossRef PubMed
  13.Lin YY, He B, Chen J, Wang ZN (2012) Can dexmedetomidine be a safe and efficacious sedative agent in post-cardiac surgery patients? A meta-analysis. Crit Care 16:R169. doi:10.1186/cc11646PubMedCentral CrossRef PubMed
  14.Lison S, Schill M, Conzen P (2007) Fast-track cardiac anesthesia: efficacy and safety of remifentanil versus sufentanil. J Cardiothorac Vasc Anesth 21:35–40. doi:10.1053/j.jvca.2006.03.011CrossRef PubMed
  15.Lotz C, Kehl F (2015) Volatile anesthetic-induced cardiac protection: molecular mechanisms, clinical aspects, and interactions with nonvolatile agents. J Cardiothorac Vasc Anesth 29:749–760. doi:10.1053/j.jvca.2014.11.012CrossRef PubMed
  16.Michelsen LG (2000) Hemodynamic effects of remifentanil in patients undergoing cardiac surgery. Anesth Analg 91:1563. doi:10.1097/00000539-200012000-00059CrossRef PubMed
  17.Schultz B, Grouven U, Schultz A (2002) Automatic classification algorithms of the EEG monitor Narcotrend for routinely recorded EEG data from general anaesthesia: a validation study. Biomed Tech (Berl) 47:9–13CrossRef
  18.Schultz B, Kreuer S, Wilhelm W, Grouven U, Schultz A (2003) [The Narcotrend monitor. Development and interpretation algorithms]. Anaesthesist 52:1143–1148. doi:10.1007/s00101-003-0603-yCrossRef PubMed
  19.Schultz A, Grouven U, Beger FA, Schultz B (2004) The Narcotrend Index: classification algorithm, correlation with propofol effect-site concentrations, and comparison with spectral parameters/Der Narcotrend-Index: klassifikationsalgorithmus, Korrelation mit Propofol-Effekt-Site-Konzentrationen und Vergleich mit Spektralparametern. Biomed Tech Eng 49:38–42CrossRef
  20.Sessler CN, Gosnell MS, Grap MJ, Brophy GM, O’Neal PV, Keane KA, Tesoro EP, Elswick RK (2012) The Richmond Agitation–Sedation Scale. Am J Respir Crit Care Med. doi:10.1164/rccm.2107138
  21.Sichrovsky TC, Mittal S, Steinberg JS (2008) Dexmedetomidine sedation leading to refractory cardiogenic shock. Anesth Analg 106:1784–1786. doi:10.1213/ane.0b013e318172fafcCrossRef PubMed
  22.Stollings JL, Diedrich DA, Oyen LJ, Brown DR (2014) Rapid-sequence intubation a review of the process and considerations when choosing medications. Ann Pharmacother 48:62–76. doi:10.1177/1060028013510488CrossRef PubMed
  23.Tempia A, Olivei MC, Calza E, Lambert H, Scotti L, Orlando E, Livigni S, Guglielmotti E (2003) The anesthetic conserving device compared with conventional circle system used under different flow conditions for inhaled anesthesia. Anesth Analg 96:1056–1061. doi:10.1213/01.ANE.0000050558.89090.95CrossRef PubMed
  24.Twersky RS, Jamerson B, Warner DS, Fleisher LA, Hogue S (2001) Hemodynamics and emergence profile of remifentanil versus fentanyl prospectively compared in a large population of surgical patients. J Clin Anesth 13:407–416. doi:10.1016/S0952-8180(01)00292-6CrossRef PubMed
  25.Vender JS, Szokol JW, Murphy GS, Nitsun M (2004) Sedation, analgesia, and neuromuscular blockade in sepsis: an evidence-based review. Crit Care Med 32:S554–S561. doi:10.1097/01.CCM.0000145907.86298.12CrossRef PubMed
  26.Warltier DC, Pagel PS, Kersten JR (2000) Approaches to the prevention of perioperative myocardial ischemia. J Am Soc Anesthesiol 92:253–253CrossRef
  27.Werdan K, Ruß M, Buerke M, Engelmann L, Ferrari M, Friedrich I, Geppert A, Graf J, Hindricks G, Janssens U, Pieske B, Prondzinsky R, Reith S, Trappe H, Zehender M, Zerkowski H, Zeymer U, Adams H, Briegel J, Delle-Karth G, Schöndube F, Schwaab B, Bode C, Christoph A, Erbel R, Fuhrmann J, Strasser R, Figulla H, Görge G, Schmitt D, Schuler G, Silber R, Tebbe U, Zwißler B (2011) Deutsch-österreichische S3-Leitlinie „Infarktbedingter kardiogener Schock – Diagnose, Monitoring und Therapie“. Intensivmed Notfallmedizin 48:291–344. doi:10.1007/s00390-011-0284-8CrossRef
  28.Zuo Z (2012) Are volatile anesthetics neuroprotective or neurotoxic? Med Gas Res 2:10. doi:10.1186/2045-9912-2-10PubMedCentral CrossRef PubMed
  29.Zwerus R, Absalom A (2015) Update on anesthetic neuroprotection. Curr Opin Anaesthesiol 28:424–430. doi:10.1097/ACO.0000000000000212CrossRef PubMed
  
• 作者单位：Dr. H. Lemm (1)
  M. Janusch (1)
  M. Buerke (1)
  
  1. Medizinische Klinik II – Kardiologie, Angiologie, Internistische Intensivmedizin, St. Marien-Krankenhaus Siegen GmbH, Kampenstraße 51, 57072, Siegen, Deutschland
  
• 刊物类别：Medicine
• 刊物主题：Medicine & Public Health
  Internal Medicine
  Medicine/Public Health, general
  
• 出版者：Urban & Vogel
• ISSN：1615-6722

文摘

Patients with cardiogenic shock pose a challenge to physicians due to cardiorespiratory instability in addition to the underlying medical condition. If analgosedation and ventilation are indicated, commonly administered drugs themselves often influence hemodynamics and oxygenation. The present article provides an overview of the available substances with consideration of the patientsʼ condition, then monitoring and optimization of analgosedation. Keywords Myocardial infarction Conscious sedation Analgesia Pharmacotherapy Ventilation